The link between monoallelic GBA1 mutations and PD emerged between 1985 and 1988 when parkinsonism was described as a possible neurological manifestation in GD patients and their relatives carrying heterozygous GBA1 mutations [260,261,262,263,264]. This evidence concerns the gene GBA1 and Parkinson disease.